IN-VITRO SUSCEPTIBILITY OF PSEUDOMONAS AERUGINOSA TO OLD AND NEW BETA -LACTAM ANTIBIOTICS AND AMINOGLYCOSIDESVAN DER AUWERA P; SCHUYTENEER F.1983; JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY; ISSN 0305-7453; GBR; DA. 1983; VOL. 11; NO 6; PP. 511-515; BIBL. 14 REF.Article

Pharmacokinetic evaluation of single daily dose amikacinVAN DER AUWERA, P.Journal of antimicrobial chemotherapy (Print). 1991, Vol 27, pp 63-71, issn 0305-7453, 9 p., SUPCArticle

Interactions between antibiotics and phagocytosis in bacterial killingVAN DER AUWERA, P.Scandinavian journal of infectious diseases. Supplementum. 1990, Num 74, pp 42-48, issn 0300-8878, 7 p.Conference Paper

Ex vivo study of serum bactericidal titers and killing rates of daptomycin (LY146032) combined or not combined with amikacin compared with those of vancomycinVAN DER AUWERA, P.Antimicrobial agents and chemotherapy. 1989, Vol 33, Num 10, pp 1783-1790, issn 0066-4804Article

Interaction of gentamicin, dibekacin, netilmicin and amikacin with various penicillins, cephalosporins, minocycline and new fluoro-quinolones against Enterobactericeae and Pseudomonas aeruginosaVAN DER AUWERA, P.Journal of antimicrobial chemotherapy (Print). 1985, Vol 16, Num 5, pp 581-587, issn 0305-7453Article

Bactericidal titers of loracarbef (LY 163892) in serum and killing rates in volunteers receiving 400 versus 200 milligramsVAN DER AUWERA, P.Antimicrobial agents and chemotherapy. 1992, Vol 36, Num 3, pp 521-526, issn 0066-4804Article

In vitro susceptibility of aerobic gram-negative blood culture isolates to oxolinic acid, norfloxacin, ciprofloxacin, enoxacin, pefloxacin, ofloxacin and oxo-enoxacinVAN DER AUWERA, P.Infection. 1986, Vol 14, Num 3, pp 142-144, issn 0300-8126Article

COMPARISON OF KELFIPRIM (SULFAMETHOPYRAZINE+TRIMETHOPRIM) AND CATRIMOXAZOLE (SULFAMETHOXAZOLE+TRIMETHOPRIM) IN URINARY TRACT INFECTIONSVAN DER AUWERA P; LEVIN S; KLASTERSKY J et al.1983; DRUGS UNDER EXPERIMENTAL AND CLINICAL RESEARCH; ISSN 0378-6501; CHE; DA. 1983; VOL. 9; NO 7; PP. 561-566; BIBL. 4 REF.Article

L'amikacine en dose unique journalière dans le traitement probabiliste du patient neutropénique fébrile: justification, efficacité et tolérance = Single daily dose of amikacin in the empiric treatment of febrile episodes in neutropenic patients : rationale, efficacy and toleranceVAN DER AUWERA, P.Médecine et maladies infectieuses. 1993, Vol 23, Num SEP, pp 60-66, issn 0399-077X, NSConference Paper

Bactericidal activity and killing rate of serum in volunteers receiving pefloxacin alone or in combination with ceftazidime, piperacillin or mezlocillin against Pseudomonas aeruginosaVAN DER AUWERA, P; HUSSON, M; KLASTERSKY, J et al.Journal of antimicrobial chemotherapy (Print). 1988, Vol 21, Num 1, pp 49-55, issn 0305-7453Article

In-vitro activity of fleroxacin (Ro 23-6240), a new fluoro-quinolone, and other agents, against Mycobacterium sppERNST, F; VAN DER AUWERA, P.Journal of antimicrobial chemotherapy (Print). 1988, Vol 21, Num 4, pp 501-504, issn 0305-7453Article

Bactericidal activity and killing rate of serum in volunteers receiving teicoplanin alone or in combination with oral or intravenous rifampinVAN DER AUWERA, P; KLASTERSKY, J.Antimicrobial agents and chemotherapy. 1987, Vol 31, Num 7, pp 1002-1005, issn 0066-4804Article

In vitro activity of LY 146032 against Staphylococcus aureus, Listeria monocytogenes, corynebacterium JK, and Bacillus spp, in comparison with various antibioticsVAN DER AUWERA, P; GRENIER, P; KLASTERSKY, J et al.Journal of antimicrobial chemotherapy (Print). 1987, Vol 20, Num 2, pp 209-212, issn 0305-7453Article

Use of the quinolones in the prophylaxis and treatment of granulocytopenic immunocompromised cancer patientsVAN DER AUWERA, P; GERAIN, J.Drugs (Basel). 1993, Vol 45, pp 81-90, issn 0012-6667, SUP3Conference Paper

In vitro and in vivo intraleukocytic accumulation of azithromycin (CP-62, 993) and its influence on ex vivo leukocyte chemiluminescenceBONNET, M; VAN DER AUWERA, P.Antimicrobial agents and chemotherapy. 1992, Vol 36, Num 6, pp 1302-1309, issn 0066-4804Article

In-vitro activity of SCH39304 in comparison with amphotericin B and fluconazoleMEUNIER, F; LAMBERT, C; VAN DER AUWERA, P et al.Journal of antimicrobial chemotherapy (Print). 1990, Vol 25, Num 2, pp 227-236, issn 0305-7453Article

L'antibiothérapie du patient cancéreux granulocytopénique = Antimicrobial therapy of granulocytopenic cancer patientVAN DER AUWERA, P; MEUNIER, F.Transactions of the Zoological Society of London. 1990, Vol 38, Num 4, pp 302-306, issn 0084-5620, 5 p.Conference Paper

In vitro activity of coumermycin alone or in combination against Staphylococcus aureus and Staphylococcus epidermidisVAN DER AUWERA, P; KLASTERSKY, J.Drugs under experimental and clinical research. 1986, Vol 12, Num 4, pp 307-311, issn 0378-6501Article

A COMPARISON OF METRONIDAZOLE AND CLINDAMYCIN FOR THE TREATMENT OF INTRAABDOMINAL ANAEROBIC INFECTION: A MULTICENTRE TRIALVAN DER AUWERA P; COLLIER J; GORIS RJA et al.1982; J. ANTIMICROB. CHEMOTHER.; ISSN 0305-7453; GBR; DA. 1982; VOL. 10; NO 1; PP. 57-66; BIBL. 2 P.Article

Serum bactericidal activity and postantibiotic effect in serum of patients with urinary tract infection receiving high-dose amikacinVAN DER AUWERA, P; KLASTERSKY, J.Antimicrobial agents and chemotherapy. 1987, Vol 31, Num 7, pp 1061-1068, issn 0066-4804Article

VANCOMYCIN THERAPY OF OXACILLIN-RESISTANT STAPHYLOCOCCUS AUREUS INFECTIONSKLASTERSKY J; COPPENS L; VAN DER AUWERA P et al.1983; JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY; ISSN 0305-7453; GBR; DA. 1983; VOL. 11; NO 4; PP. 361-367; BIBL. 12 REF.Article

Influence of teicoplanin and vancomycin on degranulation by polymorphonuclear leucocytes stimulated by various agonists : an in-vitro studyVAN DER AUWERA, P; BONNET, M; HUSSON, M et al.Journal of antimicrobial chemotherapy (Print). 1990, Vol 26, Num 5, pp 683-688, issn 0305-7453, 6 p.Article

In-vitro activity of cilofungin (LY121019) in comparison with amphotericin BMEUNIER, F; LAMBERT, C; VAN DER AUWERA, P et al.Journal of antimicrobial chemotherapy (Print). 1989, Vol 24, Num 3, pp 325-331, issn 0305-7453Article

In vitro susceptibility of Campylobacter jejuni to 27 antimicrobial agents and various combinations of B-lactams with clavulanic acid or sulbactamVAN DER AUWERA, P; SCORNEAUX, B.Antimicrobial agents and chemotherapy. 1985, Vol 28, Num 1, pp 37-40, issn 0066-4804Article

Ticarcillin-clavulanic acid therapy in severe infectionsVAN DER AUWERA, P; LEGRAND, J. C.Drugs under experimental and clinical research. 1985, Vol 11, Num 11, pp 805-813, issn 0378-6501Article